Carl Camras as shown in the faculty directory for U. of Nebraska medical center.
Carl Camras
Renowned glaucoma researcher who helped develop latanoprost, most effective drug in treating glaucoma.
OMAHA, Neb. - Carl Camras, a renowned glaucoma researcher who spent part of his career at the University of Nebraska Medical Center, died Tuesday. He was 55.
The Chicago native died of heart failure at his home in Omaha. The Heafey-Heavey-Hoffmann Dworak & Cutler funeral home in Omaha confirmed his death.
Camras helped develop latanoprost, sold under the trade name Xalatan, which has been the most effective drug to treat glaucoma. Glaucoma is a leading cause of blindness, affecting more than 2 million Americans.
Camras joined UNMC's staff in 1991. He served as chair of the Department of Ophthalmology and Visual Sciences since 2000.
April 14, 2009
Carl Camras
Memory Book
“I was one of thefortunate patients that dr. I was one of the very fortunate patients of Dr. Camras that was selected to participate in the...” Read More ยป
Posted by: Gayle Hendrickson Kimball NE
